Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Turning cold tumors hot: from molecular mechanisms to clinical applications
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 291

Showing 1-25 of 291 citing articles:

Photon-Controlled Pyroptosis Activation (PhotoPyro): An Emerging Trigger for Antitumor Immune Response
Mingle Li, Jungryun Kim, Hyeonji Rha, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 11, pp. 6007-6023
Closed Access | Times Cited: 77
CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential
Choong‐Hyun Koh, Suyoung Lee, Minkyeong Kwak, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2287-2299
Open Access | Times Cited: 74
Reactive oxygen species-powered cancer immunotherapy: Current status and challenges
Mengying He, Mengyuan Wang, Tao Xu, et al.
Journal of Controlled Release (2023) Vol. 356, pp. 623-648
Closed Access | Times Cited: 71
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
Di Huang, Xiao‐Feng Zhu, Shuying Ye, et al.
Nature (2023) Vol. 625, Iss. 7995, pp. 593-602
Closed Access | Times Cited: 67
Medicinal plant-derived mtDNA via nanovesicles induces the cGAS-STING pathway to remold tumor-associated macrophages for tumor regression
Jinfeng Liu, Jiaxin Xiang, Cuiyuan Jin, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 40
Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy
Mengke Niu, Ming Yi, Yuze Wu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 40
Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor
Tiantian Liu, Zehang Zhou, Mengxing Zhang, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 502-512
Closed Access | Times Cited: 40
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer
Takahiko Murayama, Jun Nakayama, Xinpei Jiang, et al.
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 468-491
Open Access | Times Cited: 24
T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution
Wenhui Yang, Shimao Liu, Mengyun Mao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 18
Zinc–Iron Bimetallic Peroxides Modulate the Tumor Stromal Microenvironment and Enhance Cell Immunogenicity for Enhanced Breast Cancer Immunotherapy Therapy
Yujie Lu, Youdong Chen, Guanghui Hou, et al.
ACS Nano (2024) Vol. 18, Iss. 15, pp. 10542-10556
Closed Access | Times Cited: 17
A Single‐Atom Manganese Nanozyme Mn‐N/C Promotes Anti‐Tumor Immune Response via Eliciting Type I Interferon Signaling
Wen Qiao, Jingqi Chen, Huayuan Zhou, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 16
Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer
Yuqing Chen, Dongfang Wang, Yingjie Li, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1268-1285.e7
Open Access | Times Cited: 12
Tetrahedral DNA Nanostructure with Interferon Stimulatory DNA Delivers Highly Potent Toxins and Activates the cGAS‐STING Pathway for Robust Chemotherapy and Immunotherapy
Lingpu Zhang, Yuqi Wang, Johannes Karges, et al.
Advanced Materials (2022) Vol. 35, Iss. 8
Closed Access | Times Cited: 50
Polymeric nanoparticle-based nanovaccines for cancer immunotherapy
Yongxin Zhang, Jiajing Chen, Linqi Shi, et al.
Materials Horizons (2022) Vol. 10, Iss. 2, pp. 361-392
Closed Access | Times Cited: 46
Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications
Peijie Wu, Jun Han, Yanju Gong, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 1990-1990
Open Access | Times Cited: 40
Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial
Jun Yin, Jingnan Yuan, Yunjin Li, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2068-2078
Open Access | Times Cited: 34
The future of affordable cancer immunotherapy
Niels Schaft, Jan Dörrie, Gerold Schuler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 32
Alendronate Triggered Dual‐Cascade Targeting Prodrug Nanoparticles for Enhanced Tumor Penetration and STING Activation of Osteosarcoma
Meifang Shen, Yushu Wang, Tiejun Bing, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 49
Open Access | Times Cited: 30
Beyond Drug Delivery System: Immunomodulatory Layered Double Hydroxide Nanoadjuvants Take an Essential Step Forward in Cancer Immunotherapy
Chaojie Zhu, Jianping Jiang, Yingbo Jia, et al.
Accounts of Materials Research (2023) Vol. 4, Iss. 9, pp. 758-771
Closed Access | Times Cited: 24
Engineered NanoAlum from aluminum turns cold tumor hot for potentiating cancer metalloimmunotherapy
Yingbo Jia, Jing Hu, Chaojie Zhu, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 770-783
Closed Access | Times Cited: 23
Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
Yiwen Zheng, Shujin Li, Hongchao Tang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Intimate communications within the tumor microenvironment: stromal factors function as an orchestra
Bing Cheng, Qiang Yu, Wenyu Wang
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 21
Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity
Lihui Liu, Sini Li, Yan Qu, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 10, pp. 101206-101206
Open Access | Times Cited: 21
Tertiary lymphoid structures in anticancer immunity
Jean‐Luc Teillaud, Ana Houel, Marylou Panouillot, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 9, pp. 629-646
Closed Access | Times Cited: 11
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top